Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Anti-Cancer Drug Design
|
February 4, 1998
Dimethylsilane polyamines: cytostatic compounds with potentials as anticancer drugs
F Douaud, N Le Roch, J Renault, et al.
Breast Cancer Research and Treatment
|
June 9, 2000
Polyamine profiles in tumor, normal tissue of the homologous breast, blood, and urine of breast cancer sufferers
J Levêque, F Foucher, J Y Bansard, et al.
Anticancer Research
|
November 1, 1996
Accumulation of hydroxyspermidine in red blood cells, a potential index of tumor proliferation rate
J Leveque, J G Delcros, R Havouis, et al.
The Journal of Urology
|
November 1, 1990
Erythrocyte polyamine levels in human prostatic carcinoma
B Cipolla, J P Moulinoux, V Quemener, et al.
Biochimica Et Biophysica Acta
|
May 17, 1997
Tumour growth modifies intravascular polyamine transport by plasma lipoproteins in the mouse
V Catros-Quemener, G Leray, J P Moulinoux, et al.
Anticancer Research
|
January 30, 2003
Dimethylsilane polyamines: cytostatic compounds with potentials as anticancer drugs. II. Uptake and potential cytotoxic mechanisms
N Le Roch, F Douaud, R Havouis, et al.
In Vivo (Athens, Greece)
|
September 1, 1989
In vivo antitumor activity of 4-amino 4-methyl 2-pentyne 1-al, an inhibitor of aldehyde dehydrogenase
V Quemener, G Quash, J P Moulinoux, et al.
Arzneimittel-Forschung
|
March 1, 1996
Observations with an S-adenosylmethionine decarboxylase inhibitor in rats with prostatic adenocarcinoma
N Seiler, J G Delcros, B Cipolla, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 1, 1996
Red blood cell polyamines, anaemia and tumour growth in the rat
V Quemener, J Y Bansard, M Delamaire, et al.
Anticancer Research
|
November 1, 1989
Clinical importance of erythrocyte polyamine level determination during bone marrow transplantation in children
C Bergeron, F Bouet, V Quemener, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Anti-Cancer Drug Design
|
February 4, 1998
Dimethylsilane polyamines: cytostatic compounds with potentials as anticancer drugs
F Douaud, N Le Roch, J Renault, et al.
Breast Cancer Research and Treatment
|
June 9, 2000
Polyamine profiles in tumor, normal tissue of the homologous breast, blood, and urine of breast cancer sufferers
J Levêque, F Foucher, J Y Bansard, et al.
Anticancer Research
|
November 1, 1996
Accumulation of hydroxyspermidine in red blood cells, a potential index of tumor proliferation rate
J Leveque, J G Delcros, R Havouis, et al.
The Journal of Urology
|
November 1, 1990
Erythrocyte polyamine levels in human prostatic carcinoma
B Cipolla, J P Moulinoux, V Quemener, et al.
Biochimica Et Biophysica Acta
|
May 17, 1997
Tumour growth modifies intravascular polyamine transport by plasma lipoproteins in the mouse
V Catros-Quemener, G Leray, J P Moulinoux, et al.
Anticancer Research
|
January 30, 2003
Dimethylsilane polyamines: cytostatic compounds with potentials as anticancer drugs. II. Uptake and potential cytotoxic mechanisms
N Le Roch, F Douaud, R Havouis, et al.
In Vivo (Athens, Greece)
|
September 1, 1989
In vivo antitumor activity of 4-amino 4-methyl 2-pentyne 1-al, an inhibitor of aldehyde dehydrogenase
V Quemener, G Quash, J P Moulinoux, et al.
Arzneimittel-Forschung
|
March 1, 1996
Observations with an S-adenosylmethionine decarboxylase inhibitor in rats with prostatic adenocarcinoma
N Seiler, J G Delcros, B Cipolla, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 1, 1996
Red blood cell polyamines, anaemia and tumour growth in the rat
V Quemener, J Y Bansard, M Delamaire, et al.
Anticancer Research
|
November 1, 1989
Clinical importance of erythrocyte polyamine level determination during bone marrow transplantation in children
C Bergeron, F Bouet, V Quemener, et al.
Page
of 5